NDA Partners LLC: A Development Partner to Biopharmaceutical Investors and Companies

Ronald R. Bowsher, PhD

Practice Area Focus

  • Drugs
  • Biologics
  • Diagnostics
  • Monoclonal Antibodies
  • Biosimilars
  • Novel Biomarkers


Dr. Ronald R. Bowsher joined NDA Partners as an Expert Consultant in 2016. Dr. Bowsher has four decades of drug development experience in both the pharmaceutical and CRO industries, with emphasis in biotherapeutics. He held previous positions as Chief Scientist, BioPharma Services Division, EMD Millipore Corporation and Linco Diagnostic Services, and Senior Research Scientist, Lilly Research Laboratories.

Currently, Dr. Bowsher is a Senior Research Advisor for AIT Bioscience and Chief Science Officer at B2S Life Sciences, a firm specializing in generation and life cycle management of custom biological reagents. He is a Fellow of the American Association of Pharmaceutical Scientists and was the recipient of the AAPS Distinguished Service Award in 2014. He has over 200 scientific publications and is regarded globally as a thought leader in the area of regulated bioanalysis for quantitation of drugs, biotherapeutics, biomarkers, and anti-drug antibodies.